The advent of immune checkpoint inhibitors (ICIs) has marked a paradigm shift in cancer treatment, yet a significant portion of breast cancer patients fail to respond to these therapies.

Epigenetic changes in AML can explain variation in the disease and influence prognosis and treatment choices, creating new ...

Neurogastroenterology & Motility paper describes the Auckland Classification, which is designed to bring clinical clarity to the hundreds of ...

Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma-cell disorder present in approximately 5% of the general population over the age of 50 years. MGUS is characterized ...